Showing 1-10 of 325 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Reducing Health Disparities and Improving Outcomes in Type 1 Diabetes Through a Novel Community-Focused Digital Care Model | Blue Circle Health | Leonard D'Avolio | Mission | 01-January-2026 to 31-December-2028 | $1.500.000,00 |
| GNTI-122 for the treatment of recently diagnosed type 1 diabetes | GentiBio | Mark Bach | Cures | 01-December-2025 to 30-November-2027 | $4.000.000,00 |
| Collaboration for Global T1D Care | Acora | Rebecca Goldman | Mission | 01-December-2025 to 31-January-2027 | $570.000,00 |
| Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells | Pluristyx | Benjamin Fryer | Cures | 15-November-2025 to 14-November-2027 | $704.860,20 |
| Programming Pancreatic Cell Replacement Therapeutics Using Cellgorithm Technology | Syntax Bio, Inc | Ryan Clarke | Cures | 15-November-2025 to 14-November-2027 | $856.250,00 |
| Modes of action of a beta cell targeted prodrug for preventing and treating type 1 diabetes | UT Southwestern | Wen-hong Li | Cures | 01-November-2025 to 31-October-2028 | $990.000,00 |
| Engineering fully vascularized SC-islets through endothelial integration and endocrine-vascular crosstalk | Boston Children's Hospital | Juan Melero-Martin | Cures | 01-November-2025 to 31-October-2027 | $599.994,46 |
| Exploring Immunologic Mechanisms of Indirect (Encapsulated) Islet Graft Rejection | Johns Hopkins University | Joshua Doloff | Cures | 01-November-2025 to 31-October-2028 | $1.125.000,00 |
| Pseudohypoxia to improve SC-beta engraftment | The Regents of the University of California, San Francisco | Qizhi Tang | Cures | 01-October-2025 to 30-September-2027 | $600.000,00 |
| Hydrogels for Islet Engraftment in the Porcine Subcutaneous Space | Georgia Tech Research Corporation | Andres Garcia | Cures | 01-November-2025 to 31-October-2028 | $771.544,57 |